Form 4 Filing for ABBOTT LABORATORIES

This filing details a Form 4 submission for ABBOTT LABORATORIES (ABT) concerning transactions by Director Kevin T. Conroy. On June 30, 2026, Conroy acquired 231 Stock Equivalent Units, each valued at $90.74, with the underlying security being Common Shares. These units, earned as director fees, are credited to a stock equivalent unit account under a grantor trust. The fees are generally paid in cash at age 65 or upon retirement from the board. The stock equivalent units accrue returns equivalent to investments in Abbott stock. Following this transaction, Conroy holds 231 shares.